Renaissance Capital logo

Sage Therapeutics Priced, Nasdaq: SAGE

Developing treatments for life-threatening epileptic seizures.

Industry: Health Care

First Day Return: +67.2%

Developing treatments for life-threatening epileptic seizures.
IPO Data
IPO Date 07/17/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $90
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Cambridge, MA, United States
Founded 2010
Employees at IPO 25
Website www.sagerx.com

Sage Therapeutics (SAGE) Performance

Created with Highcharts 10.3.2Chart context menuSAGE vs. IPO Index (IPOUSA)20152016201720182019202020212022202320242025-100%0%+ 100%+ 200%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index